Global Recombinant Human Parathyroid Hormone Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Recombinant Human Parathyroid Hormone market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Recombinant Human Parathyroid Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Recombinant Human Parathyroid Hormone market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Recombinant Human Parathyroid Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Recombinant Human Parathyroid Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Recombinant Human Parathyroid Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Human Parathyroid Hormone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Human Parathyroid Hormone market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NPS Pharma(Shire), Takeda, Shandong Buchang Pharmaceuticals, Ascendis Pharma and Beijing SL Pharmaceutical. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Recombinant Human Parathyroid Hormone market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Recombinant Human Parathyroid Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Parathyroid Hormone, with price, sales, revenue and global market share of Recombinant Human Parathyroid Hormone from 2018 to 2023.
Chapter 3, the Recombinant Human Parathyroid Hormone competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Parathyroid Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant Human Parathyroid Hormone market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Parathyroid Hormone.
Chapter 14 and 15, to describe Recombinant Human Parathyroid Hormone sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Recombinant Human Parathyroid Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Recombinant Human Parathyroid Hormone market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Recombinant Human Parathyroid Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Recombinant Human Parathyroid Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Recombinant Human Parathyroid Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Human Parathyroid Hormone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Human Parathyroid Hormone market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NPS Pharma(Shire), Takeda, Shandong Buchang Pharmaceuticals, Ascendis Pharma and Beijing SL Pharmaceutical. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Recombinant Human Parathyroid Hormone market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 25 mcg/dose
- 50 mcg/dose
- 75 mcg/dose
- 100 mcg/dose
- Postmenopausal Women with Osteoporosis
- Hypocalcemia in Patients with Hypoparathyroidism
- NPS Pharma(Shire)
- Takeda
- Shandong Buchang Pharmaceuticals
- Ascendis Pharma
- Beijing SL Pharmaceutical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Recombinant Human Parathyroid Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Parathyroid Hormone, with price, sales, revenue and global market share of Recombinant Human Parathyroid Hormone from 2018 to 2023.
Chapter 3, the Recombinant Human Parathyroid Hormone competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Parathyroid Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant Human Parathyroid Hormone market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Parathyroid Hormone.
Chapter 14 and 15, to describe Recombinant Human Parathyroid Hormone sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant Human Parathyroid Hormone
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant Human Parathyroid Hormone Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 25 mcg/dose
1.3.3 50 mcg/dose
1.3.4 75 mcg/dose
1.3.5 100 mcg/dose
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant Human Parathyroid Hormone Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Postmenopausal Women with Osteoporosis
1.4.3 Hypocalcemia in Patients with Hypoparathyroidism
1.5 Global Recombinant Human Parathyroid Hormone Market Size & Forecast
1.5.1 Global Recombinant Human Parathyroid Hormone Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Recombinant Human Parathyroid Hormone Sales Quantity (2018-2029)
1.5.3 Global Recombinant Human Parathyroid Hormone Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 NPS Pharma(Shire)
2.1.1 NPS Pharma(Shire) Details
2.1.2 NPS Pharma(Shire) Major Business
2.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product and Services
2.1.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 NPS Pharma(Shire) Recent Developments/Updates
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Recombinant Human Parathyroid Hormone Product and Services
2.2.4 Takeda Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Takeda Recent Developments/Updates
2.3 Shandong Buchang Pharmaceuticals
2.3.1 Shandong Buchang Pharmaceuticals Details
2.3.2 Shandong Buchang Pharmaceuticals Major Business
2.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product and Services
2.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shandong Buchang Pharmaceuticals Recent Developments/Updates
2.4 Ascendis Pharma
2.4.1 Ascendis Pharma Details
2.4.2 Ascendis Pharma Major Business
2.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Product and Services
2.4.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ascendis Pharma Recent Developments/Updates
2.5 Beijing SL Pharmaceutical
2.5.1 Beijing SL Pharmaceutical Details
2.5.2 Beijing SL Pharmaceutical Major Business
2.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product and Services
2.5.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Beijing SL Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT HUMAN PARATHYROID HORMONE BY MANUFACTURER
3.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Manufacturer (2018-2023)
3.2 Global Recombinant Human Parathyroid Hormone Revenue by Manufacturer (2018-2023)
3.3 Global Recombinant Human Parathyroid Hormone Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Recombinant Human Parathyroid Hormone by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Recombinant Human Parathyroid Hormone Manufacturer Market Share in 2022
3.4.2 Top 6 Recombinant Human Parathyroid Hormone Manufacturer Market Share in 2022
3.5 Recombinant Human Parathyroid Hormone Market: Overall Company Footprint Analysis
3.5.1 Recombinant Human Parathyroid Hormone Market: Region Footprint
3.5.2 Recombinant Human Parathyroid Hormone Market: Company Product Type Footprint
3.5.3 Recombinant Human Parathyroid Hormone Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant Human Parathyroid Hormone Market Size by Region
4.1.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2029)
4.1.2 Global Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2029)
4.1.3 Global Recombinant Human Parathyroid Hormone Average Price by Region (2018-2029)
4.2 North America Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
4.3 Europe Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
4.4 Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
4.5 South America Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
4.6 Middle East and Africa Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
5.2 Global Recombinant Human Parathyroid Hormone Consumption Value by Type (2018-2029)
5.3 Global Recombinant Human Parathyroid Hormone Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
6.2 Global Recombinant Human Parathyroid Hormone Consumption Value by Application (2018-2029)
6.3 Global Recombinant Human Parathyroid Hormone Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
7.2 North America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
7.3 North America Recombinant Human Parathyroid Hormone Market Size by Country
7.3.1 North America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2029)
7.3.2 North America Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
8.2 Europe Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
8.3 Europe Recombinant Human Parathyroid Hormone Market Size by Country
8.3.1 Europe Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2029)
8.3.2 Europe Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Recombinant Human Parathyroid Hormone Market Size by Region
9.3.1 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
10.2 South America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
10.3 South America Recombinant Human Parathyroid Hormone Market Size by Country
10.3.1 South America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2029)
10.3.2 South America Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Recombinant Human Parathyroid Hormone Market Size by Country
11.3.1 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Recombinant Human Parathyroid Hormone Market Drivers
12.2 Recombinant Human Parathyroid Hormone Market Restraints
12.3 Recombinant Human Parathyroid Hormone Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant Human Parathyroid Hormone and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Human Parathyroid Hormone
13.3 Recombinant Human Parathyroid Hormone Production Process
13.4 Recombinant Human Parathyroid Hormone Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Human Parathyroid Hormone Typical Distributors
14.3 Recombinant Human Parathyroid Hormone Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Recombinant Human Parathyroid Hormone
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant Human Parathyroid Hormone Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 25 mcg/dose
1.3.3 50 mcg/dose
1.3.4 75 mcg/dose
1.3.5 100 mcg/dose
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant Human Parathyroid Hormone Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Postmenopausal Women with Osteoporosis
1.4.3 Hypocalcemia in Patients with Hypoparathyroidism
1.5 Global Recombinant Human Parathyroid Hormone Market Size & Forecast
1.5.1 Global Recombinant Human Parathyroid Hormone Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Recombinant Human Parathyroid Hormone Sales Quantity (2018-2029)
1.5.3 Global Recombinant Human Parathyroid Hormone Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 NPS Pharma(Shire)
2.1.1 NPS Pharma(Shire) Details
2.1.2 NPS Pharma(Shire) Major Business
2.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product and Services
2.1.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 NPS Pharma(Shire) Recent Developments/Updates
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Recombinant Human Parathyroid Hormone Product and Services
2.2.4 Takeda Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Takeda Recent Developments/Updates
2.3 Shandong Buchang Pharmaceuticals
2.3.1 Shandong Buchang Pharmaceuticals Details
2.3.2 Shandong Buchang Pharmaceuticals Major Business
2.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product and Services
2.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shandong Buchang Pharmaceuticals Recent Developments/Updates
2.4 Ascendis Pharma
2.4.1 Ascendis Pharma Details
2.4.2 Ascendis Pharma Major Business
2.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Product and Services
2.4.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ascendis Pharma Recent Developments/Updates
2.5 Beijing SL Pharmaceutical
2.5.1 Beijing SL Pharmaceutical Details
2.5.2 Beijing SL Pharmaceutical Major Business
2.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product and Services
2.5.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Beijing SL Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT HUMAN PARATHYROID HORMONE BY MANUFACTURER
3.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Manufacturer (2018-2023)
3.2 Global Recombinant Human Parathyroid Hormone Revenue by Manufacturer (2018-2023)
3.3 Global Recombinant Human Parathyroid Hormone Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Recombinant Human Parathyroid Hormone by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Recombinant Human Parathyroid Hormone Manufacturer Market Share in 2022
3.4.2 Top 6 Recombinant Human Parathyroid Hormone Manufacturer Market Share in 2022
3.5 Recombinant Human Parathyroid Hormone Market: Overall Company Footprint Analysis
3.5.1 Recombinant Human Parathyroid Hormone Market: Region Footprint
3.5.2 Recombinant Human Parathyroid Hormone Market: Company Product Type Footprint
3.5.3 Recombinant Human Parathyroid Hormone Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant Human Parathyroid Hormone Market Size by Region
4.1.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2029)
4.1.2 Global Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2029)
4.1.3 Global Recombinant Human Parathyroid Hormone Average Price by Region (2018-2029)
4.2 North America Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
4.3 Europe Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
4.4 Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
4.5 South America Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
4.6 Middle East and Africa Recombinant Human Parathyroid Hormone Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
5.2 Global Recombinant Human Parathyroid Hormone Consumption Value by Type (2018-2029)
5.3 Global Recombinant Human Parathyroid Hormone Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
6.2 Global Recombinant Human Parathyroid Hormone Consumption Value by Application (2018-2029)
6.3 Global Recombinant Human Parathyroid Hormone Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
7.2 North America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
7.3 North America Recombinant Human Parathyroid Hormone Market Size by Country
7.3.1 North America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2029)
7.3.2 North America Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
8.2 Europe Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
8.3 Europe Recombinant Human Parathyroid Hormone Market Size by Country
8.3.1 Europe Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2029)
8.3.2 Europe Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Recombinant Human Parathyroid Hormone Market Size by Region
9.3.1 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
10.2 South America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
10.3 South America Recombinant Human Parathyroid Hormone Market Size by Country
10.3.1 South America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2029)
10.3.2 South America Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Recombinant Human Parathyroid Hormone Market Size by Country
11.3.1 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Recombinant Human Parathyroid Hormone Market Drivers
12.2 Recombinant Human Parathyroid Hormone Market Restraints
12.3 Recombinant Human Parathyroid Hormone Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant Human Parathyroid Hormone and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Human Parathyroid Hormone
13.3 Recombinant Human Parathyroid Hormone Production Process
13.4 Recombinant Human Parathyroid Hormone Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Human Parathyroid Hormone Typical Distributors
14.3 Recombinant Human Parathyroid Hormone Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Recombinant Human Parathyroid Hormone Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Recombinant Human Parathyroid Hormone Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. NPS Pharma(Shire) Basic Information, Manufacturing Base and Competitors
Table 4. NPS Pharma(Shire) Major Business
Table 5. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product and Services
Table 6. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. NPS Pharma(Shire) Recent Developments/Updates
Table 8. Takeda Basic Information, Manufacturing Base and Competitors
Table 9. Takeda Major Business
Table 10. Takeda Recombinant Human Parathyroid Hormone Product and Services
Table 11. Takeda Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Takeda Recent Developments/Updates
Table 13. Shandong Buchang Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Shandong Buchang Pharmaceuticals Major Business
Table 15. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product and Services
Table 16. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Shandong Buchang Pharmaceuticals Recent Developments/Updates
Table 18. Ascendis Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Ascendis Pharma Major Business
Table 20. Ascendis Pharma Recombinant Human Parathyroid Hormone Product and Services
Table 21. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ascendis Pharma Recent Developments/Updates
Table 23. Beijing SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Beijing SL Pharmaceutical Major Business
Table 25. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product and Services
Table 26. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Beijing SL Pharmaceutical Recent Developments/Updates
Table 28. Global Recombinant Human Parathyroid Hormone Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 29. Global Recombinant Human Parathyroid Hormone Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global Recombinant Human Parathyroid Hormone Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 31. Market Position of Manufacturers in Recombinant Human Parathyroid Hormone, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and Recombinant Human Parathyroid Hormone Production Site of Key Manufacturer
Table 33. Recombinant Human Parathyroid Hormone Market: Company Product Type Footprint
Table 34. Recombinant Human Parathyroid Hormone Market: Company Product Application Footprint
Table 35. Recombinant Human Parathyroid Hormone New Market Entrants and Barriers to Market Entry
Table 36. Recombinant Human Parathyroid Hormone Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2023) & (K Units)
Table 38. Global Recombinant Human Parathyroid Hormone Sales Quantity by Region (2024-2029) & (K Units)
Table 39. Global Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global Recombinant Human Parathyroid Hormone Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global Recombinant Human Parathyroid Hormone Average Price by Region (2018-2023) & (US$/Unit)
Table 42. Global Recombinant Human Parathyroid Hormone Average Price by Region (2024-2029) & (US$/Unit)
Table 43. Global Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Global Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Global Recombinant Human Parathyroid Hormone Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global Recombinant Human Parathyroid Hormone Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global Recombinant Human Parathyroid Hormone Average Price by Type (2018-2023) & (US$/Unit)
Table 48. Global Recombinant Human Parathyroid Hormone Average Price by Type (2024-2029) & (US$/Unit)
Table 49. Global Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 50. Global Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 51. Global Recombinant Human Parathyroid Hormone Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global Recombinant Human Parathyroid Hormone Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global Recombinant Human Parathyroid Hormone Average Price by Application (2018-2023) & (US$/Unit)
Table 54. Global Recombinant Human Parathyroid Hormone Average Price by Application (2024-2029) & (US$/Unit)
Table 55. North America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 56. North America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 57. North America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 58. North America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 59. North America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2023) & (K Units)
Table 60. North America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2024-2029) & (K Units)
Table 61. North America Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America Recombinant Human Parathyroid Hormone Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 66. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 67. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2023) & (K Units)
Table 68. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Country (2024-2029) & (K Units)
Table 69. Europe Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Recombinant Human Parathyroid Hormone Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 72. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 73. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 74. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 75. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2023) & (K Units)
Table 76. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Region (2024-2029) & (K Units)
Table 77. Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 80. South America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 81. South America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 82. South America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 83. South America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2023) & (K Units)
Table 84. South America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2024-2029) & (K Units)
Table 85. South America Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America Recombinant Human Parathyroid Hormone Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 88. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 89. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2023) & (K Units)
Table 92. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Region (2024-2029) & (K Units)
Table 93. Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value by Region (2024-2029) & (USD Million)
Table 95. Recombinant Human Parathyroid Hormone Raw Material
Table 96. Key Manufacturers of Recombinant Human Parathyroid Hormone Raw Materials
Table 97. Recombinant Human Parathyroid Hormone Typical Distributors
Table 98. Recombinant Human Parathyroid Hormone Typical Customers
Table 1. Global Recombinant Human Parathyroid Hormone Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Recombinant Human Parathyroid Hormone Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. NPS Pharma(Shire) Basic Information, Manufacturing Base and Competitors
Table 4. NPS Pharma(Shire) Major Business
Table 5. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product and Services
Table 6. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. NPS Pharma(Shire) Recent Developments/Updates
Table 8. Takeda Basic Information, Manufacturing Base and Competitors
Table 9. Takeda Major Business
Table 10. Takeda Recombinant Human Parathyroid Hormone Product and Services
Table 11. Takeda Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Takeda Recent Developments/Updates
Table 13. Shandong Buchang Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Shandong Buchang Pharmaceuticals Major Business
Table 15. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product and Services
Table 16. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Shandong Buchang Pharmaceuticals Recent Developments/Updates
Table 18. Ascendis Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Ascendis Pharma Major Business
Table 20. Ascendis Pharma Recombinant Human Parathyroid Hormone Product and Services
Table 21. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ascendis Pharma Recent Developments/Updates
Table 23. Beijing SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Beijing SL Pharmaceutical Major Business
Table 25. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product and Services
Table 26. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Beijing SL Pharmaceutical Recent Developments/Updates
Table 28. Global Recombinant Human Parathyroid Hormone Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 29. Global Recombinant Human Parathyroid Hormone Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global Recombinant Human Parathyroid Hormone Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 31. Market Position of Manufacturers in Recombinant Human Parathyroid Hormone, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and Recombinant Human Parathyroid Hormone Production Site of Key Manufacturer
Table 33. Recombinant Human Parathyroid Hormone Market: Company Product Type Footprint
Table 34. Recombinant Human Parathyroid Hormone Market: Company Product Application Footprint
Table 35. Recombinant Human Parathyroid Hormone New Market Entrants and Barriers to Market Entry
Table 36. Recombinant Human Parathyroid Hormone Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2023) & (K Units)
Table 38. Global Recombinant Human Parathyroid Hormone Sales Quantity by Region (2024-2029) & (K Units)
Table 39. Global Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global Recombinant Human Parathyroid Hormone Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global Recombinant Human Parathyroid Hormone Average Price by Region (2018-2023) & (US$/Unit)
Table 42. Global Recombinant Human Parathyroid Hormone Average Price by Region (2024-2029) & (US$/Unit)
Table 43. Global Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Global Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Global Recombinant Human Parathyroid Hormone Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global Recombinant Human Parathyroid Hormone Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global Recombinant Human Parathyroid Hormone Average Price by Type (2018-2023) & (US$/Unit)
Table 48. Global Recombinant Human Parathyroid Hormone Average Price by Type (2024-2029) & (US$/Unit)
Table 49. Global Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 50. Global Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 51. Global Recombinant Human Parathyroid Hormone Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global Recombinant Human Parathyroid Hormone Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global Recombinant Human Parathyroid Hormone Average Price by Application (2018-2023) & (US$/Unit)
Table 54. Global Recombinant Human Parathyroid Hormone Average Price by Application (2024-2029) & (US$/Unit)
Table 55. North America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 56. North America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 57. North America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 58. North America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 59. North America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2023) & (K Units)
Table 60. North America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2024-2029) & (K Units)
Table 61. North America Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America Recombinant Human Parathyroid Hormone Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 66. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 67. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2023) & (K Units)
Table 68. Europe Recombinant Human Parathyroid Hormone Sales Quantity by Country (2024-2029) & (K Units)
Table 69. Europe Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Recombinant Human Parathyroid Hormone Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 72. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 73. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 74. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 75. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2023) & (K Units)
Table 76. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Region (2024-2029) & (K Units)
Table 77. Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 80. South America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 81. South America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 82. South America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 83. South America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2018-2023) & (K Units)
Table 84. South America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2024-2029) & (K Units)
Table 85. South America Recombinant Human Parathyroid Hormone Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America Recombinant Human Parathyroid Hormone Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Type (2018-2023) & (K Units)
Table 88. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Type (2024-2029) & (K Units)
Table 89. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Region (2018-2023) & (K Units)
Table 92. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Region (2024-2029) & (K Units)
Table 93. Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value by Region (2024-2029) & (USD Million)
Table 95. Recombinant Human Parathyroid Hormone Raw Material
Table 96. Key Manufacturers of Recombinant Human Parathyroid Hormone Raw Materials
Table 97. Recombinant Human Parathyroid Hormone Typical Distributors
Table 98. Recombinant Human Parathyroid Hormone Typical Customers
LIST OF FIGURES
Figure 1. Recombinant Human Parathyroid Hormone Picture
Figure 2. Global Recombinant Human Parathyroid Hormone Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Type in 2022
Figure 4. 25 mcg/dose Examples
Figure 5. 50 mcg/dose Examples
Figure 6. 75 mcg/dose Examples
Figure 7. 100 mcg/dose Examples
Figure 8. Global Recombinant Human Parathyroid Hormone Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Application in 2022
Figure 10. Postmenopausal Women with Osteoporosis Examples
Figure 11. Hypocalcemia in Patients with Hypoparathyroidism Examples
Figure 12. Global Recombinant Human Parathyroid Hormone Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Recombinant Human Parathyroid Hormone Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Recombinant Human Parathyroid Hormone Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Recombinant Human Parathyroid Hormone Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Recombinant Human Parathyroid Hormone by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Recombinant Human Parathyroid Hormone Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Recombinant Human Parathyroid Hormone Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Recombinant Human Parathyroid Hormone Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Recombinant Human Parathyroid Hormone Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Recombinant Human Parathyroid Hormone Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Recombinant Human Parathyroid Hormone Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value Market Share by Region (2018-2029)
Figure 54. China Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Recombinant Human Parathyroid Hormone Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Recombinant Human Parathyroid Hormone Market Drivers
Figure 75. Recombinant Human Parathyroid Hormone Market Restraints
Figure 76. Recombinant Human Parathyroid Hormone Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Recombinant Human Parathyroid Hormone in 2022
Figure 79. Manufacturing Process Analysis of Recombinant Human Parathyroid Hormone
Figure 80. Recombinant Human Parathyroid Hormone Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Recombinant Human Parathyroid Hormone Picture
Figure 2. Global Recombinant Human Parathyroid Hormone Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Type in 2022
Figure 4. 25 mcg/dose Examples
Figure 5. 50 mcg/dose Examples
Figure 6. 75 mcg/dose Examples
Figure 7. 100 mcg/dose Examples
Figure 8. Global Recombinant Human Parathyroid Hormone Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Application in 2022
Figure 10. Postmenopausal Women with Osteoporosis Examples
Figure 11. Hypocalcemia in Patients with Hypoparathyroidism Examples
Figure 12. Global Recombinant Human Parathyroid Hormone Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Recombinant Human Parathyroid Hormone Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Recombinant Human Parathyroid Hormone Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Recombinant Human Parathyroid Hormone Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Recombinant Human Parathyroid Hormone by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Recombinant Human Parathyroid Hormone Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Recombinant Human Parathyroid Hormone Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Recombinant Human Parathyroid Hormone Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Recombinant Human Parathyroid Hormone Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Recombinant Human Parathyroid Hormone Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Recombinant Human Parathyroid Hormone Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Recombinant Human Parathyroid Hormone Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value Market Share by Region (2018-2029)
Figure 54. China Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Recombinant Human Parathyroid Hormone Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Recombinant Human Parathyroid Hormone Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Recombinant Human Parathyroid Hormone Market Drivers
Figure 75. Recombinant Human Parathyroid Hormone Market Restraints
Figure 76. Recombinant Human Parathyroid Hormone Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Recombinant Human Parathyroid Hormone in 2022
Figure 79. Manufacturing Process Analysis of Recombinant Human Parathyroid Hormone
Figure 80. Recombinant Human Parathyroid Hormone Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
